nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Clonidine—glaucoma	0.0908	0.172	CbGbCtD
Rivaroxaban—CYP3A4—Pilocarpine—glaucoma	0.0725	0.138	CbGbCtD
Rivaroxaban—ABCB1—Timolol—glaucoma	0.0695	0.132	CbGbCtD
Rivaroxaban—ABCB1—Clonidine—glaucoma	0.0591	0.112	CbGbCtD
Rivaroxaban—CYP3A4—Brinzolamide—glaucoma	0.0569	0.108	CbGbCtD
Rivaroxaban—CYP3A4—Dorzolamide—glaucoma	0.0549	0.104	CbGbCtD
Rivaroxaban—CYP3A4—Methazolamide—glaucoma	0.049	0.0929	CbGbCtD
Rivaroxaban—CYP3A4—Acetazolamide—glaucoma	0.0391	0.0743	CbGbCtD
Rivaroxaban—CYP3A4—Clonidine—glaucoma	0.0354	0.0672	CbGbCtD
Rivaroxaban—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—DHPS—glaucoma	0.00781	0.174	CbGpPWpGaD
Rivaroxaban—CYP2J2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00537	0.12	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C1QB—glaucoma	0.002	0.0447	CbGpPWpGaD
Rivaroxaban—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00153	0.0342	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—C3—glaucoma	0.00138	0.0307	CbGpPWpGaD
Rivaroxaban—CYP2J2—Tryptophan metabolism—CYP1B1—glaucoma	0.00133	0.0296	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—DHPS—glaucoma	0.00128	0.0285	CbGpPWpGaD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00124	0.0276	CbGpPWpGaD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00107	0.0239	CbGpPWpGaD
Rivaroxaban—CYP2J2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00106	0.0236	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000869	0.0194	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—CTSA—glaucoma	0.000797	0.0178	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C3—glaucoma	0.00078	0.0174	CbGpPWpGaD
Rivaroxaban—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.000715	0.0159	CbGpPWpGaD
Rivaroxaban—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000655	0.0146	CbGpPWpGaD
Rivaroxaban—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00064	0.0143	CbGpPWpGaD
Rivaroxaban—Sinusitis—Betaxolol—glaucoma	0.000611	0.00143	CcSEcCtD
Rivaroxaban—Abdominal pain—Apraclonidine—glaucoma	0.00061	0.00142	CcSEcCtD
Rivaroxaban—Nervous system disorder—Brinzolamide—glaucoma	0.00061	0.00142	CcSEcCtD
Rivaroxaban—Angiopathy—Clonidine—glaucoma	0.00061	0.00142	CcSEcCtD
Rivaroxaban—Rash—Latanoprost—glaucoma	0.000609	0.00142	CcSEcCtD
Rivaroxaban—Agranulocytosis—Betaxolol—glaucoma	0.000608	0.00142	CcSEcCtD
Rivaroxaban—Dermatitis—Latanoprost—glaucoma	0.000608	0.00142	CcSEcCtD
Rivaroxaban—Dyspepsia—Acetazolamide—glaucoma	0.000608	0.00142	CcSEcCtD
Rivaroxaban—Tachycardia—Brinzolamide—glaucoma	0.000607	0.00142	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—DHPS—glaucoma	0.000606	0.0135	CbGpPWpGaD
Rivaroxaban—Mediastinal disorder—Clonidine—glaucoma	0.000606	0.00141	CcSEcCtD
Rivaroxaban—Headache—Latanoprost—glaucoma	0.000605	0.00141	CcSEcCtD
Rivaroxaban—Skin disorder—Brinzolamide—glaucoma	0.000604	0.00141	CcSEcCtD
Rivaroxaban—Oedema—Pilocarpine—glaucoma	0.000598	0.0014	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000596	0.00139	CcSEcCtD
Rivaroxaban—Fatigue—Acetazolamide—glaucoma	0.000595	0.00139	CcSEcCtD
Rivaroxaban—Infection—Pilocarpine—glaucoma	0.000594	0.00139	CcSEcCtD
Rivaroxaban—Nausea—Methazolamide—glaucoma	0.000592	0.00138	CcSEcCtD
Rivaroxaban—Hypotension—Dorzolamide—glaucoma	0.000591	0.00138	CcSEcCtD
Rivaroxaban—Dyspnoea—Brimonidine—glaucoma	0.000591	0.00138	CcSEcCtD
Rivaroxaban—Hypotension—Travoprost—glaucoma	0.000589	0.00138	CcSEcCtD
Rivaroxaban—Shock—Pilocarpine—glaucoma	0.000588	0.00137	CcSEcCtD
Rivaroxaban—Tachycardia—Pilocarpine—glaucoma	0.000584	0.00136	CcSEcCtD
Rivaroxaban—Dyspepsia—Brimonidine—glaucoma	0.000583	0.00136	CcSEcCtD
Rivaroxaban—Angina pectoris—Timolol—glaucoma	0.000582	0.00136	CcSEcCtD
Rivaroxaban—Hypotension—Brinzolamide—glaucoma	0.000581	0.00136	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—GSTT1—glaucoma	0.000579	0.0129	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Brimonidine—glaucoma	0.000572	0.00134	CcSEcCtD
Rivaroxaban—Fatigue—Brimonidine—glaucoma	0.000571	0.00133	CcSEcCtD
Rivaroxaban—Feeling abnormal—Acetazolamide—glaucoma	0.000569	0.00133	CcSEcCtD
Rivaroxaban—Hypersensitivity—Apraclonidine—glaucoma	0.000569	0.00133	CcSEcCtD
Rivaroxaban—Pain—Brimonidine—glaucoma	0.000567	0.00132	CcSEcCtD
Rivaroxaban—Dyspnoea—Dorzolamide—glaucoma	0.000564	0.00132	CcSEcCtD
Rivaroxaban—Muscle spasms—Clonidine—glaucoma	0.000562	0.00131	CcSEcCtD
Rivaroxaban—Dyspnoea—Travoprost—glaucoma	0.000562	0.00131	CcSEcCtD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000559	0.0125	CbGpPWpGaD
Rivaroxaban—Hypotension—Pilocarpine—glaucoma	0.000559	0.0013	CcSEcCtD
Rivaroxaban—Dyspepsia—Dorzolamide—glaucoma	0.000557	0.0013	CcSEcCtD
Rivaroxaban—Dyspnoea—Brinzolamide—glaucoma	0.000555	0.0013	CcSEcCtD
Rivaroxaban—Dyspepsia—Travoprost—glaucoma	0.000555	0.0013	CcSEcCtD
Rivaroxaban—Asthenia—Apraclonidine—glaucoma	0.000554	0.00129	CcSEcCtD
Rivaroxaban—Urticaria—Acetazolamide—glaucoma	0.000548	0.00128	CcSEcCtD
Rivaroxaban—Dyspepsia—Brinzolamide—glaucoma	0.000548	0.00128	CcSEcCtD
Rivaroxaban—Eye disorder—Betaxolol—glaucoma	0.000547	0.00128	CcSEcCtD
Rivaroxaban—Pruritus—Apraclonidine—glaucoma	0.000546	0.00128	CcSEcCtD
Rivaroxaban—Fatigue—Dorzolamide—glaucoma	0.000546	0.00127	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Travoprost—glaucoma	0.000544	0.00127	CcSEcCtD
Rivaroxaban—Fatigue—Travoprost—glaucoma	0.000543	0.00127	CcSEcCtD
Rivaroxaban—Cardiac disorder—Betaxolol—glaucoma	0.000543	0.00127	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Clonidine—glaucoma	0.000543	0.00127	CcSEcCtD
Rivaroxaban—Pain—Dorzolamide—glaucoma	0.000541	0.00126	CcSEcCtD
Rivaroxaban—Pain—Travoprost—glaucoma	0.000539	0.00126	CcSEcCtD
Rivaroxaban—Constipation—Travoprost—glaucoma	0.000539	0.00126	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000537	0.00125	CcSEcCtD
Rivaroxaban—Asthenia—Bimatoprost—glaucoma	0.000537	0.00125	CcSEcCtD
Rivaroxaban—Fatigue—Brinzolamide—glaucoma	0.000536	0.00125	CcSEcCtD
Rivaroxaban—Angioedema—Clonidine—glaucoma	0.000535	0.00125	CcSEcCtD
Rivaroxaban—Dyspnoea—Pilocarpine—glaucoma	0.000533	0.00125	CcSEcCtD
Rivaroxaban—Pain—Brinzolamide—glaucoma	0.000532	0.00124	CcSEcCtD
Rivaroxaban—Angiopathy—Betaxolol—glaucoma	0.000531	0.00124	CcSEcCtD
Rivaroxaban—Pruritus—Bimatoprost—glaucoma	0.000529	0.00124	CcSEcCtD
Rivaroxaban—Immune system disorder—Betaxolol—glaucoma	0.000528	0.00123	CcSEcCtD
Rivaroxaban—Diarrhoea—Apraclonidine—glaucoma	0.000528	0.00123	CcSEcCtD
Rivaroxaban—Malaise—Clonidine—glaucoma	0.000528	0.00123	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Betaxolol—glaucoma	0.000527	0.00123	CcSEcCtD
Rivaroxaban—Dyspepsia—Pilocarpine—glaucoma	0.000526	0.00123	CcSEcCtD
Rivaroxaban—Syncope—Clonidine—glaucoma	0.000525	0.00123	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dorzolamide—glaucoma	0.000521	0.00122	CcSEcCtD
Rivaroxaban—Feeling abnormal—Travoprost—glaucoma	0.000519	0.00121	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dorzolamide—glaucoma	0.000517	0.00121	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000516	0.00121	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Travoprost—glaucoma	0.000515	0.0012	CcSEcCtD
Rivaroxaban—Loss of consciousness—Clonidine—glaucoma	0.000514	0.0012	CcSEcCtD
Rivaroxaban—Feeling abnormal—Brinzolamide—glaucoma	0.000513	0.0012	CcSEcCtD
Rivaroxaban—Pain—Pilocarpine—glaucoma	0.000511	0.00119	CcSEcCtD
Rivaroxaban—Constipation—Pilocarpine—glaucoma	0.000511	0.00119	CcSEcCtD
Rivaroxaban—Dizziness—Apraclonidine—glaucoma	0.00051	0.00119	CcSEcCtD
Rivaroxaban—Urticaria—Dorzolamide—glaucoma	0.000503	0.00117	CcSEcCtD
Rivaroxaban—Epistaxis—Timolol—glaucoma	0.000502	0.00117	CcSEcCtD
Rivaroxaban—Abdominal pain—Dorzolamide—glaucoma	0.0005	0.00117	CcSEcCtD
Rivaroxaban—Sinusitis—Timolol—glaucoma	0.0005	0.00117	CcSEcCtD
Rivaroxaban—Chest pain—Clonidine—glaucoma	0.000498	0.00116	CcSEcCtD
Rivaroxaban—Abdominal pain—Travoprost—glaucoma	0.000498	0.00116	CcSEcCtD
Rivaroxaban—Agranulocytosis—Timolol—glaucoma	0.000497	0.00116	CcSEcCtD
Rivaroxaban—Asthenia—Acetazolamide—glaucoma	0.000495	0.00116	CcSEcCtD
Rivaroxaban—Dizziness—Bimatoprost—glaucoma	0.000495	0.00116	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000495	0.00116	CcSEcCtD
Rivaroxaban—Urticaria—Brinzolamide—glaucoma	0.000494	0.00115	CcSEcCtD
Rivaroxaban—Feeling abnormal—Pilocarpine—glaucoma	0.000493	0.00115	CcSEcCtD
Rivaroxaban—Discomfort—Clonidine—glaucoma	0.000492	0.00115	CcSEcCtD
Rivaroxaban—Vomiting—Apraclonidine—glaucoma	0.000491	0.00115	CcSEcCtD
Rivaroxaban—Muscle spasms—Betaxolol—glaucoma	0.00049	0.00114	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Pilocarpine—glaucoma	0.000489	0.00114	CcSEcCtD
Rivaroxaban—Hypersensitivity—Brimonidine—glaucoma	0.000488	0.00114	CcSEcCtD
Rivaroxaban—Dry mouth—Clonidine—glaucoma	0.000487	0.00114	CcSEcCtD
Rivaroxaban—Dermatitis—Apraclonidine—glaucoma	0.000486	0.00114	CcSEcCtD
Rivaroxaban—Headache—Apraclonidine—glaucoma	0.000483	0.00113	CcSEcCtD
Rivaroxaban—Oedema—Clonidine—glaucoma	0.000477	0.00112	CcSEcCtD
Rivaroxaban—Asthenia—Brimonidine—glaucoma	0.000475	0.00111	CcSEcCtD
Rivaroxaban—Infection—Clonidine—glaucoma	0.000474	0.00111	CcSEcCtD
Rivaroxaban—Abdominal pain—Pilocarpine—glaucoma	0.000473	0.0011	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Betaxolol—glaucoma	0.000473	0.0011	CcSEcCtD
Rivaroxaban—Diarrhoea—Acetazolamide—glaucoma	0.000472	0.0011	CcSEcCtD
Rivaroxaban—Rash—Bimatoprost—glaucoma	0.000472	0.0011	CcSEcCtD
Rivaroxaban—Dermatitis—Bimatoprost—glaucoma	0.000471	0.0011	CcSEcCtD
Rivaroxaban—Anaemia—Betaxolol—glaucoma	0.000471	0.0011	CcSEcCtD
Rivaroxaban—Shock—Clonidine—glaucoma	0.00047	0.0011	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Timolol—glaucoma	0.00047	0.0011	CcSEcCtD
Rivaroxaban—Pruritus—Brimonidine—glaucoma	0.000469	0.00109	CcSEcCtD
Rivaroxaban—Headache—Bimatoprost—glaucoma	0.000469	0.00109	CcSEcCtD
Rivaroxaban—Nervous system disorder—Clonidine—glaucoma	0.000468	0.00109	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dorzolamide—glaucoma	0.000466	0.00109	CcSEcCtD
Rivaroxaban—Tachycardia—Clonidine—glaucoma	0.000466	0.00109	CcSEcCtD
Rivaroxaban—Hypersensitivity—Travoprost—glaucoma	0.000464	0.00108	CcSEcCtD
Rivaroxaban—Skin disorder—Clonidine—glaucoma	0.000464	0.00108	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—CYP1B1—glaucoma	0.000461	0.0103	CbGpPWpGaD
Rivaroxaban—Malaise—Betaxolol—glaucoma	0.000459	0.00107	CcSEcCtD
Rivaroxaban—Nausea—Apraclonidine—glaucoma	0.000458	0.00107	CcSEcCtD
Rivaroxaban—Hypersensitivity—Brinzolamide—glaucoma	0.000458	0.00107	CcSEcCtD
Rivaroxaban—Syncope—Betaxolol—glaucoma	0.000457	0.00107	CcSEcCtD
Rivaroxaban—Dizziness—Acetazolamide—glaucoma	0.000456	0.00107	CcSEcCtD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP1B1—glaucoma	0.000455	0.0101	CbGpPWpGaD
Rivaroxaban—Asthenia—Dorzolamide—glaucoma	0.000454	0.00106	CcSEcCtD
Rivaroxaban—Asthenia—Travoprost—glaucoma	0.000452	0.00106	CcSEcCtD
Rivaroxaban—Pruritus—Dorzolamide—glaucoma	0.000448	0.00105	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betaxolol—glaucoma	0.000448	0.00105	CcSEcCtD
Rivaroxaban—Eye disorder—Timolol—glaucoma	0.000447	0.00104	CcSEcCtD
Rivaroxaban—Asthenia—Brinzolamide—glaucoma	0.000446	0.00104	CcSEcCtD
Rivaroxaban—Hypotension—Clonidine—glaucoma	0.000446	0.00104	CcSEcCtD
Rivaroxaban—Pruritus—Travoprost—glaucoma	0.000446	0.00104	CcSEcCtD
Rivaroxaban—Nausea—Bimatoprost—glaucoma	0.000444	0.00104	CcSEcCtD
Rivaroxaban—Cardiac disorder—Timolol—glaucoma	0.000444	0.00104	CcSEcCtD
Rivaroxaban—Hypersensitivity—Pilocarpine—glaucoma	0.000441	0.00103	CcSEcCtD
Rivaroxaban—Pruritus—Brinzolamide—glaucoma	0.00044	0.00103	CcSEcCtD
Rivaroxaban—Vomiting—Acetazolamide—glaucoma	0.000439	0.00103	CcSEcCtD
Rivaroxaban—Dizziness—Brimonidine—glaucoma	0.000438	0.00102	CcSEcCtD
Rivaroxaban—Angiopathy—Timolol—glaucoma	0.000434	0.00101	CcSEcCtD
Rivaroxaban—Chest pain—Betaxolol—glaucoma	0.000434	0.00101	CcSEcCtD
Rivaroxaban—Diarrhoea—Dorzolamide—glaucoma	0.000433	0.00101	CcSEcCtD
Rivaroxaban—Headache—Acetazolamide—glaucoma	0.000432	0.00101	CcSEcCtD
Rivaroxaban—Immune system disorder—Timolol—glaucoma	0.000432	0.00101	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000431	0.00961	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Travoprost—glaucoma	0.000431	0.00101	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Timolol—glaucoma	0.000431	0.00101	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000431	0.00101	CcSEcCtD
Rivaroxaban—Asthenia—Pilocarpine—glaucoma	0.000429	0.001	CcSEcCtD
Rivaroxaban—Discomfort—Betaxolol—glaucoma	0.000428	0.001	CcSEcCtD
Rivaroxaban—Dyspnoea—Clonidine—glaucoma	0.000426	0.000994	CcSEcCtD
Rivaroxaban—Diarrhoea—Brinzolamide—glaucoma	0.000426	0.000994	CcSEcCtD
Rivaroxaban—Dry mouth—Betaxolol—glaucoma	0.000424	0.000991	CcSEcCtD
Rivaroxaban—Pruritus—Pilocarpine—glaucoma	0.000423	0.000988	CcSEcCtD
Rivaroxaban—Dizziness—Dorzolamide—glaucoma	0.000418	0.000977	CcSEcCtD
Rivaroxaban—Rash—Brimonidine—glaucoma	0.000418	0.000976	CcSEcCtD
Rivaroxaban—Dermatitis—Brimonidine—glaucoma	0.000417	0.000975	CcSEcCtD
Rivaroxaban—Dizziness—Travoprost—glaucoma	0.000417	0.000973	CcSEcCtD
Rivaroxaban—Oedema—Betaxolol—glaucoma	0.000416	0.000971	CcSEcCtD
Rivaroxaban—Headache—Brimonidine—glaucoma	0.000415	0.000969	CcSEcCtD
Rivaroxaban—Infection—Betaxolol—glaucoma	0.000413	0.000965	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Clonidine—glaucoma	0.000412	0.000963	CcSEcCtD
Rivaroxaban—Fatigue—Clonidine—glaucoma	0.000412	0.000961	CcSEcCtD
Rivaroxaban—Dizziness—Brinzolamide—glaucoma	0.000411	0.000961	CcSEcCtD
Rivaroxaban—Nausea—Acetazolamide—glaucoma	0.00041	0.000958	CcSEcCtD
Rivaroxaban—Diarrhoea—Pilocarpine—glaucoma	0.000409	0.000956	CcSEcCtD
Rivaroxaban—Shock—Betaxolol—glaucoma	0.000409	0.000955	CcSEcCtD
Rivaroxaban—Pain—Clonidine—glaucoma	0.000408	0.000954	CcSEcCtD
Rivaroxaban—Constipation—Clonidine—glaucoma	0.000408	0.000954	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betaxolol—glaucoma	0.000408	0.000952	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—NARFL—glaucoma	0.000406	0.00905	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CA5A—glaucoma	0.000406	0.00905	CbGpPWpGaD
Rivaroxaban—Tachycardia—Betaxolol—glaucoma	0.000406	0.000948	CcSEcCtD
Rivaroxaban—Skin disorder—Betaxolol—glaucoma	0.000404	0.000943	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000404	0.009	CbGpPWpGaD
Rivaroxaban—Vomiting—Dorzolamide—glaucoma	0.000402	0.00094	CcSEcCtD
Rivaroxaban—Rash—Dorzolamide—glaucoma	0.000399	0.000932	CcSEcCtD
Rivaroxaban—Dermatitis—Dorzolamide—glaucoma	0.000399	0.000931	CcSEcCtD
Rivaroxaban—Rash—Travoprost—glaucoma	0.000397	0.000928	CcSEcCtD
Rivaroxaban—Dermatitis—Travoprost—glaucoma	0.000397	0.000927	CcSEcCtD
Rivaroxaban—Headache—Dorzolamide—glaucoma	0.000396	0.000926	CcSEcCtD
Rivaroxaban—Vomiting—Brinzolamide—glaucoma	0.000396	0.000924	CcSEcCtD
Rivaroxaban—Dizziness—Pilocarpine—glaucoma	0.000395	0.000923	CcSEcCtD
Rivaroxaban—Headache—Travoprost—glaucoma	0.000395	0.000922	CcSEcCtD
Rivaroxaban—Nausea—Brimonidine—glaucoma	0.000394	0.000919	CcSEcCtD
Rivaroxaban—Feeling abnormal—Clonidine—glaucoma	0.000393	0.000919	CcSEcCtD
Rivaroxaban—Rash—Brinzolamide—glaucoma	0.000392	0.000916	CcSEcCtD
Rivaroxaban—Dermatitis—Brinzolamide—glaucoma	0.000392	0.000915	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Clonidine—glaucoma	0.00039	0.000912	CcSEcCtD
Rivaroxaban—Headache—Brinzolamide—glaucoma	0.00039	0.00091	CcSEcCtD
Rivaroxaban—Hypotension—Betaxolol—glaucoma	0.000388	0.000907	CcSEcCtD
Rivaroxaban—Angioedema—Timolol—glaucoma	0.00038	0.000888	CcSEcCtD
Rivaroxaban—Vomiting—Pilocarpine—glaucoma	0.00038	0.000888	CcSEcCtD
Rivaroxaban—Urticaria—Clonidine—glaucoma	0.000379	0.000886	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—CTSA—glaucoma	0.000378	0.00844	CbGpPWpGaD
Rivaroxaban—Abdominal pain—Clonidine—glaucoma	0.000377	0.000882	CcSEcCtD
Rivaroxaban—Rash—Pilocarpine—glaucoma	0.000377	0.000881	CcSEcCtD
Rivaroxaban—Dermatitis—Pilocarpine—glaucoma	0.000377	0.00088	CcSEcCtD
Rivaroxaban—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000376	0.00839	CbGpPWpGaD
Rivaroxaban—Nausea—Dorzolamide—glaucoma	0.000376	0.000878	CcSEcCtD
Rivaroxaban—Headache—Pilocarpine—glaucoma	0.000375	0.000875	CcSEcCtD
Rivaroxaban—Nausea—Travoprost—glaucoma	0.000374	0.000874	CcSEcCtD
Rivaroxaban—Syncope—Timolol—glaucoma	0.000373	0.000872	CcSEcCtD
Rivaroxaban—Dyspnoea—Betaxolol—glaucoma	0.000371	0.000866	CcSEcCtD
Rivaroxaban—Nausea—Brinzolamide—glaucoma	0.000369	0.000863	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—GSTM1—glaucoma	0.000369	0.00823	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000367	0.00819	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Betaxolol—glaucoma	0.000366	0.000855	CcSEcCtD
Rivaroxaban—Loss of consciousness—Timolol—glaucoma	0.000366	0.000854	CcSEcCtD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTM1—glaucoma	0.000364	0.00811	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Betaxolol—glaucoma	0.000359	0.000838	CcSEcCtD
Rivaroxaban—Fatigue—Betaxolol—glaucoma	0.000358	0.000837	CcSEcCtD
Rivaroxaban—Pain—Betaxolol—glaucoma	0.000355	0.00083	CcSEcCtD
Rivaroxaban—Constipation—Betaxolol—glaucoma	0.000355	0.00083	CcSEcCtD
Rivaroxaban—Nausea—Pilocarpine—glaucoma	0.000355	0.00083	CcSEcCtD
Rivaroxaban—Chest pain—Timolol—glaucoma	0.000354	0.000827	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000352	0.000822	CcSEcCtD
Rivaroxaban—Hypersensitivity—Clonidine—glaucoma	0.000352	0.000822	CcSEcCtD
Rivaroxaban—Discomfort—Timolol—glaucoma	0.00035	0.000817	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—ACE2—glaucoma	0.000348	0.00776	CbGpPWpGaD
Rivaroxaban—Dry mouth—Timolol—glaucoma	0.000346	0.000809	CcSEcCtD
Rivaroxaban—Asthenia—Clonidine—glaucoma	0.000343	0.0008	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betaxolol—glaucoma	0.000343	0.0008	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Timolol—glaucoma	0.00034	0.000793	CcSEcCtD
Rivaroxaban—Oedema—Timolol—glaucoma	0.00034	0.000793	CcSEcCtD
Rivaroxaban—Pruritus—Clonidine—glaucoma	0.000338	0.000789	CcSEcCtD
Rivaroxaban—Infection—Timolol—glaucoma	0.000337	0.000788	CcSEcCtD
Rivaroxaban—Shock—Timolol—glaucoma	0.000334	0.00078	CcSEcCtD
Rivaroxaban—Nervous system disorder—Timolol—glaucoma	0.000333	0.000778	CcSEcCtD
Rivaroxaban—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000333	0.00741	CbGpPWpGaD
Rivaroxaban—Urticaria—Betaxolol—glaucoma	0.00033	0.000771	CcSEcCtD
Rivaroxaban—Skin disorder—Timolol—glaucoma	0.00033	0.00077	CcSEcCtD
Rivaroxaban—Diarrhoea—Clonidine—glaucoma	0.000327	0.000763	CcSEcCtD
Rivaroxaban—Hypotension—Timolol—glaucoma	0.000317	0.000741	CcSEcCtD
Rivaroxaban—Dizziness—Clonidine—glaucoma	0.000316	0.000737	CcSEcCtD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000309	0.00689	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Betaxolol—glaucoma	0.000306	0.000715	CcSEcCtD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000305	0.0068	CbGpPWpGaD
Rivaroxaban—Vomiting—Clonidine—glaucoma	0.000304	0.000709	CcSEcCtD
Rivaroxaban—Dyspnoea—Timolol—glaucoma	0.000303	0.000707	CcSEcCtD
Rivaroxaban—Rash—Clonidine—glaucoma	0.000301	0.000703	CcSEcCtD
Rivaroxaban—Dermatitis—Clonidine—glaucoma	0.000301	0.000703	CcSEcCtD
Rivaroxaban—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000301	0.00671	CbGpPWpGaD
Rivaroxaban—Headache—Clonidine—glaucoma	0.000299	0.000699	CcSEcCtD
Rivaroxaban—Dyspepsia—Timolol—glaucoma	0.000299	0.000698	CcSEcCtD
Rivaroxaban—Asthenia—Betaxolol—glaucoma	0.000298	0.000697	CcSEcCtD
Rivaroxaban—Pruritus—Betaxolol—glaucoma	0.000294	0.000687	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Timolol—glaucoma	0.000293	0.000685	CcSEcCtD
Rivaroxaban—Fatigue—Timolol—glaucoma	0.000293	0.000684	CcSEcCtD
Rivaroxaban—Pain—Timolol—glaucoma	0.00029	0.000678	CcSEcCtD
Rivaroxaban—Diarrhoea—Betaxolol—glaucoma	0.000284	0.000664	CcSEcCtD
Rivaroxaban—Nausea—Clonidine—glaucoma	0.000284	0.000662	CcSEcCtD
Rivaroxaban—Feeling abnormal—Timolol—glaucoma	0.00028	0.000654	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Timolol—glaucoma	0.000278	0.000649	CcSEcCtD
Rivaroxaban—Dizziness—Betaxolol—glaucoma	0.000275	0.000642	CcSEcCtD
Rivaroxaban—Urticaria—Timolol—glaucoma	0.00027	0.00063	CcSEcCtD
Rivaroxaban—Abdominal pain—Timolol—glaucoma	0.000268	0.000627	CcSEcCtD
Rivaroxaban—Vomiting—Betaxolol—glaucoma	0.000264	0.000617	CcSEcCtD
Rivaroxaban—Rash—Betaxolol—glaucoma	0.000262	0.000612	CcSEcCtD
Rivaroxaban—Dermatitis—Betaxolol—glaucoma	0.000262	0.000612	CcSEcCtD
Rivaroxaban—Headache—Betaxolol—glaucoma	0.00026	0.000608	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00025	0.00558	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Timolol—glaucoma	0.00025	0.000584	CcSEcCtD
Rivaroxaban—Nausea—Betaxolol—glaucoma	0.000247	0.000577	CcSEcCtD
Rivaroxaban—Asthenia—Timolol—glaucoma	0.000244	0.000569	CcSEcCtD
Rivaroxaban—Pruritus—Timolol—glaucoma	0.00024	0.000561	CcSEcCtD
Rivaroxaban—F10—Hemostasis—TGFB2—glaucoma	0.000233	0.00518	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Timolol—glaucoma	0.000232	0.000543	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000226	0.00504	CbGpPWpGaD
Rivaroxaban—Dizziness—Timolol—glaucoma	0.000225	0.000525	CcSEcCtD
Rivaroxaban—Vomiting—Timolol—glaucoma	0.000216	0.000504	CcSEcCtD
Rivaroxaban—Rash—Timolol—glaucoma	0.000214	0.0005	CcSEcCtD
Rivaroxaban—Dermatitis—Timolol—glaucoma	0.000214	0.0005	CcSEcCtD
Rivaroxaban—Headache—Timolol—glaucoma	0.000213	0.000497	CcSEcCtD
Rivaroxaban—Nausea—Timolol—glaucoma	0.000202	0.000471	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—CA1—glaucoma	0.000198	0.00442	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CTSA—glaucoma	0.000192	0.00428	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—PAX6—glaucoma	0.000186	0.00414	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CA2—glaucoma	0.000181	0.00404	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000178	0.00396	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000177	0.00395	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000177	0.00395	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SOD1—glaucoma	0.000176	0.00393	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000175	0.00389	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000167	0.00372	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00016	0.00357	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1A—glaucoma	0.00015	0.00335	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000144	0.0032	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000142	0.00316	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MMP1—glaucoma	0.000134	0.003	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FAS—glaucoma	0.000134	0.00299	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000133	0.00297	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—C3—glaucoma	0.000132	0.00295	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000131	0.00292	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CAV1—glaucoma	0.000129	0.00287	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TXN—glaucoma	0.000128	0.00285	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FN1—glaucoma	0.000123	0.00273	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA5A—glaucoma	0.000117	0.00261	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NARFL—glaucoma	0.000117	0.00261	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000117	0.00261	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000117	0.0026	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000116	0.0026	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000115	0.00257	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000113	0.00252	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000108	0.00241	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—glaucoma	0.000106	0.00237	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP1—glaucoma	0.000106	0.00236	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	0.000105	0.00234	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTT1—glaucoma	9.91e-05	0.00221	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—glaucoma	9.74e-05	0.00217	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA5A—glaucoma	8.83e-05	0.00197	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NARFL—glaucoma	8.83e-05	0.00197	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.44e-05	0.00188	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP2—glaucoma	8.18e-05	0.00182	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.99e-05	0.00178	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCA1—glaucoma	7.89e-05	0.00176	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP1B1—glaucoma	7.89e-05	0.00176	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.78e-05	0.00173	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.76e-05	0.00173	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.73e-05	0.00172	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.67e-05	0.00171	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.22e-05	0.00161	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—glaucoma	7.02e-05	0.00157	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.64e-05	0.00148	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.61e-05	0.00147	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—glaucoma	6.31e-05	0.00141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.18e-05	0.00138	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.1e-05	0.00136	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA1—glaucoma	5.71e-05	0.00127	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—glaucoma	5.69e-05	0.00127	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.66e-05	0.00126	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—glaucoma	5.58e-05	0.00124	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CTSA—glaucoma	5.53e-05	0.00123	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NARFL—glaucoma	5.44e-05	0.00121	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA5A—glaucoma	5.44e-05	0.00121	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—glaucoma	5.3e-05	0.00118	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.29e-05	0.00118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA2—glaucoma	5.23e-05	0.00117	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—glaucoma	5.19e-05	0.00116	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAV1—glaucoma	5.14e-05	0.00115	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.94e-05	0.0011	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.88e-05	0.00109	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA1—glaucoma	4.31e-05	0.000961	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CTSA—glaucoma	4.18e-05	0.000931	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.16e-05	0.000927	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA2—glaucoma	3.94e-05	0.000879	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.94e-05	0.000878	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—glaucoma	3.89e-05	0.000867	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TXN—glaucoma	3.68e-05	0.000821	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—glaucoma	3.56e-05	0.000793	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.28e-05	0.000731	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—glaucoma	2.85e-05	0.000636	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.81e-05	0.000626	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TXN—glaucoma	2.78e-05	0.000619	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA1—glaucoma	2.66e-05	0.000592	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CTSA—glaucoma	2.57e-05	0.000574	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.48e-05	0.000552	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA2—glaucoma	2.43e-05	0.000542	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCA1—glaucoma	2.27e-05	0.000507	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1B1—glaucoma	2.27e-05	0.000507	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—glaucoma	2.15e-05	0.00048	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—glaucoma	1.82e-05	0.000405	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1B1—glaucoma	1.72e-05	0.000383	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCA1—glaucoma	1.72e-05	0.000383	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TXN—glaucoma	1.71e-05	0.000382	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—glaucoma	1.61e-05	0.000358	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—glaucoma	1.5e-05	0.000334	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—glaucoma	1.48e-05	0.00033	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—glaucoma	1.37e-05	0.000306	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—glaucoma	1.33e-05	0.000296	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—glaucoma	1.21e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—glaucoma	1.13e-05	0.000252	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—glaucoma	1.12e-05	0.00025	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—glaucoma	1.12e-05	0.000249	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCA1—glaucoma	1.06e-05	0.000236	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1B1—glaucoma	1.06e-05	0.000236	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—glaucoma	1.03e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—glaucoma	8.46e-06	0.000189	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—glaucoma	8.45e-06	0.000188	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—glaucoma	7.74e-06	0.000172	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—glaucoma	7.47e-06	0.000167	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—glaucoma	6.96e-06	0.000155	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—glaucoma	6.89e-06	0.000154	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—glaucoma	5.21e-06	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—glaucoma	4.77e-06	0.000106	CbGpPWpGaD
